Infertility Market Information; By Sex (Males, Females And Unexplained), By Diagnosis (Men Diagnostic Tests (Semen Analysis, Genetic Testing, Testicular Biopsy, And Other) And Women Diagnostic Tests (Hysteroscopy, Laparoscopy, Ovulation Testing, Hysterosalpingography And Others)) And General Diagnostic Tests (Genetic Testing, Hormone Testing, Microscopic Analysis, Imaging, And Others), By Drugs (Clomiphene Citrate, Letrozole, Serophene, Hormone Treatment And Others), By Techniques (Assisted Reproductive Technology (Art), Intrauterine In...

Infertility Market Overview

In the simplest of terms, infertility can be defined as the incapacity in both males and females to produce offspring. Fertility services provide effective treatments for curing infertility. These can be used to resolve infertility issues in the LGBT community, single parents, and couples older than the childbearing age. A few of the various methods are In Vitro Fertilization (IVF), surrogacy, artificial insemination, and many others. The deficiencies in semen or egg production can hamper the process of carrying a pregnancy to its full term and delivering a healthy child.

The Infertility Market Share is anticipated to increase at a faster rate in the coming future. The Infertility Market Size will rise with a CAGR of 4.6% by the year 2023. The total Infertility Market Value amounted to USD 11.2 billion in the year 2016. 

COVID 19 Analysis

People across the globe are being affected by Coronavirus, the global pandemic. It has negatively impacted the operations of all the industries, except for the pharmaceutical industry. There has been a complete lockdown situation in almost every part of the world and people are forced to stay at their homes. Every nation has sealed their borders which mean no international travel will be possible shortly. The businesses are also being shut down. Many people were laid off from their workplaces. This has affected the Infertility industry Growth as well.

It is being anticipated that post the Covid19 situation, Infertility industry Share will grow tremendously. Irregular or absent menstrual periods and other ovulatory problems are some of the Post-Covid19 symptoms. This has increased the number of cases of infertility among women. Pregnant ladies who were infected by Covid19 have undergone several complications. The government is taking active initiatives to take good care of pregnant women’s health in such conditions.

Figure 1  Infertility Market by Models, 2016 (% Market Share)

 

Market Dynamics

Drivers

The fertility rate is declining among both men and women owing to the sedentary lifestyle. People getting married at an elderly age, working couples planning for having children, substance abuse, other environmental factors, genetic abnormalities, stressful lifestyle, obesity, prostate cancer, and many other reasons are driving the fertility services market.

Opportunities

Fertility in both men and women is being affected by unhealthy lifestyles and hazardous environmental changes. Fertility services have become a blessing for both single parents and same-sex parents. The number of fertility clinics is also increasing which is directly providing a vast market for fertility services.

Restraints

Unawareness about the new technologies as well as unwillingness to trust the procedures of fertility services is becoming the major hindrance in the growth and development of  infertility market. Some of the methods are expensive and all people cannot afford the same. The government in several regions is not very supportive of fertility services.

Value Chain Analysis

The fertility rate is the measure of the average number of children per woman. It is declining constantly for the past several years owing to reasons such as substance abuse, other environmental factors, genetic abnormalities, stressful lifestyle, obesity, prostate cancer, and many others. The key market players are making significant advances in the respective fields so that fertility options can easily be adopted by parents who are incapable of siring a child. 

Market Segmentation

According to the Infertility Market Analysis, it can be divided into various segments. These are based on patient type, based on diagnostic tests, based on drugs and techniques.

Based on patient type

Patients making use of fertility services can be male, female, and the other gender. Infertility can be commonly seen in women and the female segment is holding the largest market share.

Based on diagnostic tests

On its basis, the infertility market can be further segments into male, female, and general diagnostic tests. The male diagnostic test includes semen analysis, genetic testing, testicular biopsy, and other tests. Female diagnostic tests include hysteroscopy, laparoscopy, ovulation testing, etc. Other tests can be genetic testing, hormone testing, microscopic analysis, and imaging.

Based on Drugs and techniques

Various drugs used for hormone treatment are clomiphene citrate, letrozole, Serophene, and others. Some of the techniques used in infertility services are assisted reproductive technology (ART), intrauterine or artificial insemination, and tubal surgeries, etc.

Regional Analysis

The Infertility Market Value is increasing rapidly. It is leaving a huge impression in every part of the world owing to its specialization and advancements. The regions of the operation of infertility market include regions of America, Europe, Asia-pacific, and the rest of the world.

American region, which includes the area of North America (the US and Canada) and Latin America, provides the largest market for fertility services. This owns to a high level of awareness among people, maximum disposable income, and active government initiatives for promoting childbirth. 

The European region, which includes Germany, UK, France, Russia, and Italy, is also expanding and holds the second-largest market share of the infertility market. This owns to advancements in technologies and highly invested research and development projects.

Asia-Pacific region includes countries such as China, Japan, India, Australia, and South Korea, is growing tremendously throughout the forecasted period. The developing countries are providing a promising market for fertility services. The population is very large and the rate of male infertility is high in South East Asia. 

The rest of the world region, which includes the region of the Middle East and Africa, is growing at a slower but constant rate owing to the lower technological development, lack of awareness, and fewer government initiatives.

Competitive Landscape

The list of major Infertility Market Key Players is as follows:

• Olympus Corporation


• The Cooper Companies Inc.


• Virtus Health


• CooperSurgical, Inc.


• Vitro life CARE Fertility


• INVO Bioscience


• Monash IVF


• Fertility Focus


• Carolinas Fertility Institute


• Apollo Hospitals Enterprise Ltd.


• Merck KGaA, LABOTECT GMBH


• Genea Limited


• Medicover


• The Johns Hopkins Hospital


• Progyny, Inc.


• Millendo Therapeutics, Inc.


• FUJIFILM Irvine Scientific

These companies form joint ventures or come together in partnerships for certain projects, mergers, and acquisitions to make technological advancements. They strive to develop end-products and services that are unique, cost-effective, and proficient in working and can deliver accurate solutions to the respective problems.

Recent Developments

The various recent activities found in the Infertility Market Forecast are as follows:

• In July of the year 2019, Vitrolife care fertility formed a joint venture with Prime Tech. this collaboration was designed to promote the Piezo technique as it has better Intracytoplasmic Sperm Injection (ICSI) procedures and results in human IVF and it was globally accepted.


• In March of the year 2018, Vitrolife AB, a Sweden-based company, got the approval for selling and promoting its time-lapse incubator, called EmbryoScope in the US and other regions. This helped the company in expanding its market visibility in the infertility treatment industry.


• In March of the year 2018, Genea Limited, an Australian company, expanded its operations by establishing a new fertility clinic in Melbourne. This has given the company a chance to expand its operations in the nearby regions.


• In April of the year 2018, Baker Ruskinn, situated in the UK, formed a partnership with I&L Biosystems UK Ltd., another UK-based organization. They are working together as UK sales partners and they aim to expand its selling and distribution business throughout the area of UK and strengthen its market position.

Report Overview

This report about the Infertility Market Trends includes the following elements:

• Market Overview


• COVID19 Analysis


• Market Dynamics


• Value Chain Analysis


• Market Segmentation


• Regional Analysis


• Competitive Landscape


• Recent Developments

This research report provides a comprehensive study about the Infertility Market Outlook. It includes a thorough analysis of its market trends and the areas of new advancements. The fertility rate is declining among both men and women owing to the sedentary lifestyle. A few of the various methods used in infertility services are In Vitro Fertilization (IVF), surrogacy, artificial insemination, and many others.

Report Scope:

Report Attribute/Metric	Details
Market Size	2027: Significant Value
CAGR	4.6 % (2018-2023)
Base Year	2019
Forecast Period	2020-2027
Historical Data	2018
Forecast Units	Value (USD Million)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Sex, Diagnosis, Drugs and Techniques
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Halotech DNA, SCSA Diagnostics, Inc., Andrology Solutions, Zydus Cadila Healthcare Ltd, Androvia LifeSciences, Aetna Inc., Bayer Healthcare, EMD Serono, Inc
Key Market Opportunities	stress, obesity and increasing age at marriage
Key Market Drivers	substance abuse environmental factors and genetic abnormalities

Speak to Analyst Ask for Customization